Amlodipine and Valsartan Tablets USP 10mg/160mg, 30 count bottles recall — FDA D-1036-2019
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.